Cellectricon Launches World’s First System for High Throughput RNAi Screening

Cellectricon, a leading provider of screening solutions for drug discovery, today announced the launch of the new Cellaxess^® HT System. The world’s first fully automated high throughput transfection system enables reagent-free delivery of genetic material to a wide range of biologically relevant cell types. The system will be introduced at the SBS 14th Annual Conference and Meeting in St. Louis, MO, USA, April 6-10.

Cellectricon has developed Cellaxess^®HT in close collaboration with leading research groups to meet the increasing demand for a technology capable of genome-wide RNAi screening.

"We are very pleased to meet the industry’s demand by bringing this state-of-the-art system to the market.” says Dr. Mattias Karlsson, CEO of Cellectricon. “Cellaxess^®HT will revolutionize target discovery by opening the door to using more biologically relevant cell types in genome-wide RNAi screening.”

About the Cellaxess^®HT system
Cellaxess^®HT addresses the critical need for high throughput delivery of siRNA and cDNA to hard to transfect cells in several cell-based screening assays. Cellaxess^®HT is the only fully automated system on the market allowing for high throughput transfection of cells in culture directly in 384-well microplates. The system enables reagent-free delivery to a wide range of biologically relevant cell types with excellent efficiency and viability at a throughput of 50 000 wells per day.